Senseonics, Incorporated is an innovative medical device company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products. Our mission is to help people with diabetes live their lives confidently and with ease.

Senseonics, Inc.

Eversense Diabetes Website

Eversense USA Eversense Outside USA

Patient - Footer Menu - Column Four

CONTACT US
ABOUT US
- How we started
- What we believe
DMS LOGIN

DISCLAIMER

The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration twice per day, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see https://eversensediabetes.com/safety-info/.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

MKT-5143-01-001 Rev 2

Footer Menu - Copyright

EULA
Privacy Policy
Legal
Safety
Contact Us